Skip to main content

Respiratory Organ Aging and Cancer

  • Living reference work entry
  • First Online:
Geriatric Oncology

Abstract

Lung aging begins in the third decade, initiating a gradual decline in maximal pulmonary function that continues throughout the remainder of life. Lung aging may mimic obstructive and restrictive lung diseases. Lung parenchyma loses elasticity via alveolar wall and mesenchymal degradation and distortion, similar to emphysema. Muscles of respiration become sarcopenic and weaken, while the thorax contorts due to osteoporotic vertebral fractures, all of which manifest as a restrictive lung function pattern. Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) and their pathogenesis may be related to accelerated cellular aging. Chronic lung disease impacts cardiopulmonary fitness, which can lead to decreased physical exertion and resultant frailty.

Lung cancer incidence also increases with age and is increased in older adults with COPD and IPF. Lung cancer is the leading cancer-related cause of death in the world. Most lung cancer in the USA is attributable to smoking. Globally, indoor air pollution is also a significant risk factor. Approximately 85% of lung cancer is non-small cell lung cancer (NSCLC), and adenocarcinoma is the predominant histologic type. Depending on stage at diagnosis, treatment options can include surgical resection, medical therapy (e.g., chemotherapy, driver mutation-targeted agents, and immunotherapy), and radiation therapy (photon or proton). Best care practices mandate that multidisciplinary teams formulate treatment plans to optimize care. Comprehensive geriatric assessments are useful decision-making tools and may improve survival while limiting treatment toxicity. Surgical resection impacts post-operative lung function, so preoperative evaluations must include pulmonary function testing with additional cardiopulmonary testing as indicated. Early palliative care interventions should be a cornerstone of medical management in advanced lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • ACS. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.

    Google Scholar 

  • AJCC 2017. AJCC cancer staging manual, Springer: New York.

    Google Scholar 

  • Albain KS, Swann RS, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374:379–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224–37.

    Article  CAS  PubMed  Google Scholar 

  • Beckert AK, Huisingh-Scheetz M, Thompson K, Celauro AD, Williams J, Pachwicewicz P, Ferguson MK. Screening for frailty in thoracic surgical patients. Ann Thorac Surg. 2017;103:956–61.

    Article  PubMed  Google Scholar 

  • Bergethon K, Shaw AT, Ignatius Ou S-H, Katayama R, Lovly CM, Mcdonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang R. Ros1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol. 2012;30:863–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bezjak A, Temin S, Franklin G, Giaccone G, Govindan R, Johnson ML, Rimner A, Schneider BJ, Strawn J, Azzoli CG. Definitive and adjuvant radiotherapy in locally advanced non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based clinical practice guideline. J Clin Oncol. 2015;33:2100–5.

    Article  PubMed  Google Scholar 

  • Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O’riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med. 2013;189:214–22.

    Article  Google Scholar 

  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–81.

    CAS  PubMed  Google Scholar 

  • Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer. N Engl J Med. 2015;373:1627–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–24.

    Article  CAS  PubMed  Google Scholar 

  • Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer. N Engl J Med. 2015;373:123–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier J-P, Varela G, Licker M, Ferguson M, Faivre-Finn C, Huber RM. Ers/Ests clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34:17–41.

    Article  CAS  PubMed  Google Scholar 

  • Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2013;143:E166s–90s.

    Article  CAS  Google Scholar 

  • Burri PH. Structural aspects of postnatal lung development–alveolar formation and growth. Neonatology. 2006;89:313–22.

    Article  Google Scholar 

  • Bush A. Lung development and aging. Ann Am Thorac Soc. 2016;13:S438–46.

    Article  PubMed  Google Scholar 

  • Camus P, Bonniaud P, Camus C, Foucher P, Jacquet L. Pneumotox – an updated time-saving web resource. Eur Respir J. 2013;42:5043.

    Google Scholar 

  • Caramori G, Adcock IM, Casolari P, Ito K, Jazrawi E, Tsaprouni L, Villetti G, Civelli M, Carnini C, Chung KF. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax. 2011;2010:156448.

    Google Scholar 

  • Castriotta RJ, Eldadah BA, Foster WM, Halter JB, Hazzard WR, Kiley JP, King TE, Horne FM, Nayfield SG, Reynolds HY. Workshop on idiopathic pulmonary fibrosis in older adults. Chest J. 2010;138:693–703.

    Article  Google Scholar 

  • Cavaliere S, Venuta F, Foccoli P, Toninelli C, La Face B. Endoscopic treatment of malignant airway obstructions in 2,008 patients. Chest. 1996;110:1536–42.

    Article  CAS  PubMed  Google Scholar 

  • Celli BR, Cote CG, Marin JM, Casanova C, Montes De Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–12.

    Article  CAS  PubMed  Google Scholar 

  • Cerfolio RJ, Bryant AS. Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg. 2009;88:917–23.

    Article  PubMed  Google Scholar 

  • Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, Mcrae SE, Widder J, Feng L. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chilosi M, Carloni A, Rossi A, Poletti V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl Res. 2013;162:156–73.

    Article  CAS  PubMed  Google Scholar 

  • Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2013;143:E437s–54s.

    Article  Google Scholar 

  • Corre R, Greillier L, Le Caër H, Audigier-Valette C, Baize N, Bérard H, Falchero L, Monnet I, Dansin E, Vergnenègre A. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non–small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol. 2016;34:1476–83.

    Article  CAS  PubMed  Google Scholar 

  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel J-P, Rolland Y, Schneider SM. Sarcopenia: European consensus on definition and diagnosis report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cuffe S, Booth CM, Peng Y, Darling GE, Li G, Kong W, Mackillop WJ, Shepherd FA. Adjuvant chemotherapy for non–small-cell lung cancer in the elderly: a population-based study in Ontario, Canada. J Clin Oncol. 2012;30:1813–21.

    Article  PubMed  Google Scholar 

  • Darby S, Hill D, Auvinen A, Barros-Dios J, Baysson H, Bochicchio F, Deo H, Falk R, Forastiere F, Hakama M. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ. 2005;330:223.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davidoff AJ, Tang M, Seal B, Edelman MJ. Chemotherapy and survival benefit in elderly patients with advanced non–small-cell lung cancer. J Clin Oncol. 2010;28:2191–7.

    Article  PubMed  Google Scholar 

  • De Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, Pueyo JC, Villanueva A, Lozano MAD, Montes U. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest J. 2007;132:1932–8.

    Article  Google Scholar 

  • Egan TM, Murray S, Bustami R, Shearon T, Mccullough KP, Edwards L, Coke M, Garrity E, Sweet S, Heiney D. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6:1212–27.

    Article  CAS  PubMed  Google Scholar 

  • Eguchi T, Bains S, Lee M-C, Tan KS, Hristov B, Buitrago DH, Bains MS, Downey RJ, Huang J, Isbell JM. Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non–small-cell lung cancer: a competing risks analysis. J Clin Oncol. 2016;35(3):281–90.

    Article  PubMed  PubMed Central  Google Scholar 

  • Enright PL, Kronmal RA, Manolio TA, Schenker MB, Hyatt R. Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. Am J Respir Crit Care Med. 1994;149:430–8.

    Article  CAS  PubMed  Google Scholar 

  • Evison M, Crosbie PA, Martin J, Bishop P, Doran H, Joseph L, Chaturvedi A, Barber PV, Booton R. EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes. J Thorac Oncol. 2014;9:370–6.

    Article  PubMed  Google Scholar 

  • Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25:1824–31.

    Article  PubMed  Google Scholar 

  • Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, Defelice J, Levine RM, Lubiner ET, Reyes P, Schreiber FJ. Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (Crash) score. Cancer. 2012;118:3377–86.

    Article  PubMed  Google Scholar 

  • Fasano M, Della Corte CM, Papaccio F, Ciardiello F, Morgillo F. Pulmonary large-cell neuroendocrine carcinoma: from epidemiology to therapy. J Thorac Oncol. 2015;10:1133–41.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ferguson MK, Gaissert HA, Grab JD, Sheng S. Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity. J Thorac Cardiovasc Surg. 2009;138:1297–302.

    Article  PubMed  Google Scholar 

  • Ferguson MK, Watson S, Johnson E, Vigneswaran WT. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg. 2014;45:660–4.

    Article  PubMed  Google Scholar 

  • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fontham ET, Correa P, Reynolds P, Wu-Williams A, Buffler PA, Greenberg RS, Chen VW, Alterman T, Boyd P, Austin DF. Environmental tobacco smoke and lung cancer in nonsmoking women: a multicenter study. JAMA. 1994;271:1752–9.

    Article  CAS  PubMed  Google Scholar 

  • Fragoso CAV, Enright PL, Mcavay G, Van Ness PH, Gill TM. Frailty and respiratory impairment in older persons. Am J Med. 2012;125:79–86.

    Article  Google Scholar 

  • Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G. Frailty in older adults evidence for a phenotype. J Gerontol Ser A Biol Med Sci. 2001;56:M146–57.

    Article  CAS  Google Scholar 

  • Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346:1061–6.

    Article  PubMed  Google Scholar 

  • Fried TR, Fragoso CAV, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA. 2012a;308:1254–63.

    Article  CAS  PubMed  Google Scholar 

  • Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease: “I was worried that he didn’t have much room to decline”. JAMA. 2012b;308:1254. https://doi.org/10.1001/Jama.2012.12422.

    Article  CAS  PubMed  Google Scholar 

  • Gajra A, Jatoi A. Non–small-cell lung cancer in elderly patients: a discussion of treatment options. J Clin Oncol. 2014;32:2562–9.

    Article  CAS  PubMed  Google Scholar 

  • GOLD. Global initiative for chronic obstructive lung disease (GOLD). 2017.

    Google Scholar 

  • Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L, Committee, I. A. F. T. S. O. L. C. I. S. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706–14.

    Article  PubMed  Google Scholar 

  • Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.

    Article  PubMed  Google Scholar 

  • Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153:976–80.

    Article  CAS  PubMed  Google Scholar 

  • Group, E. L. C. V. I. S. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999;91:66–72.

    Article  Google Scholar 

  • Group, I. A. L. C. T. C. Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer. N Engl J Med. 2004;2004:351–60.

    Google Scholar 

  • Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L. Asthma in the elderly: current understanding and future research needs – a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011;128:S4–S24.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hardie J, Buist AS, Vollmer W, Ellingsen I, Bakke P, Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20:1117–22.

    Article  CAS  PubMed  Google Scholar 

  • Ho SF, O'mahony MS, Steward JA, Breay P, Buchalter M, Burr ML. Dyspnoea and quality of life in older people at home. Age Ageing. 2001;30:155–9.

    Article  CAS  PubMed  Google Scholar 

  • Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Cl K, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975–2013. Bethesda: National Cancer Institute; 2016.

    Google Scholar 

  • Huijnen B, Van Der Horst F, Van Amelsvoort L, Wesseling G, Lansbergen M, Aarts P, Nicolson N, Knottnerus A. Dyspnea in elderly family practice patients. Occurrence, severity, quality of life and mortality over an 8-year period. Fam Pract. 2006;23:34–9.

    Article  PubMed  Google Scholar 

  • Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29:3457–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Inoue Y, Inui N, Asada K, Karayama M, Matsuda H, Yokomura K, Koshimizu N, Imokawa S, Yamada T, Shirai T. Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Cancer Chemother Pharmacol. 2015;76:155–61.

    Article  CAS  PubMed  Google Scholar 

  • Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest J. 2012;141:222–31.

    Article  Google Scholar 

  • Janssen-Heijnen M, Maas H, Van De Schans S, Coebergh J, Groen H. Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it? Ann Oncol. 2010;22(4):821–826.

    Article  PubMed  Google Scholar 

  • Janssens J-P. Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion. Clin Chest Med. 2005;26:469–84.

    Article  PubMed  Google Scholar 

  • Janssens J-P, Pache J-C, Nicod L. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13:197–205.

    Article  CAS  PubMed  Google Scholar 

  • Jett JR, Schild SE, Kesler KA, Kalemkerian GP. Treatment of small cell lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2013;143:E400s–19s.

    Article  CAS  Google Scholar 

  • Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL, Polkey MI, Man WD. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70:213–8.

    Article  PubMed  Google Scholar 

  • Kale MS, Mhango G, Gomez JE, Sigel K, Smith CB, Bonomi M, Wisnivesky JP. Treatment toxicity in elderly patients with advanced non-small cell lung cancer. Am J Clin Oncol. 2017;40(5):470–476.

    Article  PubMed  PubMed Central  Google Scholar 

  • Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. 1948;1:634–56.

    Article  Google Scholar 

  • King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083–92.

    Article  CAS  PubMed  Google Scholar 

  • Kwak N, Park C-M, Lee J, Park YS, Lee S-M, Yim J-J, Yoo C-G, Kim YW, Han SK, Lee C-H. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med. 2014;108:524–30.

    Article  PubMed  Google Scholar 

  • Lahousse L, Ziere G, Verlinden VJ, Zillikens MC, Uitterlinden AG, Rivadeneira F, Tiemeier H, Joos GF, Hofman A, Ikram MA. Risk of frailty in elderly with COPD: a population-based study. J Gerontol Ser A Biol Med Sci. 2016;71:689–95.

    Article  CAS  Google Scholar 

  • Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373:111–22.

    Article  CAS  PubMed  Google Scholar 

  • Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49:171–80.

    Article  PubMed  Google Scholar 

  • Leech JA, Dulberg C, Kellie S, Pattee L, Gay J. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis. 1990;141:68.

    Article  CAS  PubMed  Google Scholar 

  • Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431–40.

    Article  PubMed  Google Scholar 

  • Lin H-H, Murray M, Cohen T, Colijn C, Ezzati M. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet. 2008;372:1473–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar J-S, Squire J. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol. 2013;8:823–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Luoto JA, Elmståhl S, Wollmer P, Pihlsgård M. Incidence of airflow limitation in subjects 65–100 years of age. Eur Respir J. 2015. http://erj.ersjournals.com/content/erj/early/2015/12/17/13993003.00635-2015.full.pdf

  • Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013;119:1381–5.

    Article  PubMed  Google Scholar 

  • Macmahon H, Naidich DP, Goo JM, Lee KS, Leung AN, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284:228–43.

    Article  PubMed  Google Scholar 

  • Macnee W. Is chronic obstructive pulmonary disease an accelerated aging disease? Ann Am Thorac Soc. 2016;13:S429–37.

    Article  PubMed  Google Scholar 

  • Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–6.

    Article  CAS  PubMed  Google Scholar 

  • Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non—small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol. 2005;23:6865–72.

    Article  PubMed  Google Scholar 

  • Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, Takenaga R, Devgan L, Holzmueller CG, Tian J. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901–8.

    Article  PubMed  Google Scholar 

  • Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–28.

    Article  PubMed  PubMed Central  Google Scholar 

  • Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH. Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2015;33:3488–515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mcgarry RC, Song G, Des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121:1155–8.

    Article  PubMed  Google Scholar 

  • Mckee BJ, Regis SM, Mckee AB, Flacke S, Wald C. Performance of ACR lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2016;13:R25–9.

    Article  PubMed  Google Scholar 

  • Mcwilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, Yasufuku K, Martel S, Laberge F, Gingras M. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369:910–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Medicare CF & Services M. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439n). 2015.

    Google Scholar 

  • Meiners S, Eickelberg O, Königshoff M. Hallmarks of the ageing lung. Eur Respir J. 2015;45(3):807–27.

    Article  CAS  PubMed  Google Scholar 

  • Mercado N, Ito K, Barnes PJ. Accelerated ageing of the lung in COPD: new concepts. Thorax. 2015;70(5):482–9.

    Article  PubMed  Google Scholar 

  • Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, Jaklitsch MT. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest J. 2005;128:237–45.

    Article  Google Scholar 

  • Micke P, Faldum A, Metz T, Beeh K-M, Bittinger F, Hengstler J-G, Buhl R. Staging small cell lung cancer: veterans administration lung study group versus international association for the study of lung cancer – what limits limited disease? Lung Cancer. 2002;37:271–6.

    Article  PubMed  Google Scholar 

  • Miner B, Tinetti ME, Van Ness PH, Han L, Leo-Summers L, Newman AB, Lee PJ, Vaz Fragoso CA. Dyspnea in community-dwelling older persons: a multifactorial geriatric health condition. J Am Geriatr Soc. 2016;64:2042–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, García-Río F. Characterisation of the overlap COPD – asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107:1053–60.

    Article  PubMed  Google Scholar 

  • Mittal N, Raj R, Islam EA, Nugent K. The frequency of frailty in ambulatory patients with chronic lung diseases. J Prim Care Community Health. 2016;7:10–5.

    Article  PubMed  Google Scholar 

  • Mora AL, Bueno M, Rojas M. Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis. J Clin Investig. 2017;127:405.

    Article  PubMed  PubMed Central  Google Scholar 

  • Morla M, Busquets X, Pons J, Sauleda J, Macnee W, Agusti A. Telomere shortening in smokers with and without COPD. Eur Respir J. 2006;27:525–8.

    Article  CAS  PubMed  Google Scholar 

  • Moyer VA. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330–8.

    PubMed  Google Scholar 

  • Murgu SD. Diagnosing and staging lung cancer involving the mediastinum. Chest J. 2015;147:1401–12.

    Article  Google Scholar 

  • Naidoo J, Wang X, Woo KM, Iyriboz T, Halpenny D, Cunningham J, Chaft JE, Segal NH, Callahan MK, Lesokhin AM, Rosenberg J. Pneumonitis in patients treated with anti–programmed death-1/programmed death ligand 1 therapy. J Clin Oncol. 2017;35(7):709.

    Article  CAS  PubMed  Google Scholar 

  • NCHS. Health, United States, 2015: with special feature on racial and ethnic health disparities. Hyattsville: National Center For Health Statistics; 2016.

    Google Scholar 

  • Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9:274–84.

    Article  CAS  PubMed  Google Scholar 

  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–56.

    Article  CAS  PubMed  Google Scholar 

  • Parashar B, Edwards A, Mehta R, Pasmantier M, Wernicke AG, Sabbas A, Kerestez RS, Nori D, Chao KC. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol. 2011;34:160–4.

    PubMed  Google Scholar 

  • Pardo A, Selman M. Lung fibroblasts, aging, and idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2016;13:S417–21.

    Article  PubMed  Google Scholar 

  • Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–52.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pavel ME, Hainsworth JD, Baudin E, Peeters M, Hörsch D, Winkler RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study. Lancet. 2011;378:2005–12.

    Article  CAS  PubMed  Google Scholar 

  • Pelayo Alvarez M, Gallego Rubio Ó, Bonfill Cosp X, Agra Varela Y. Chemotherapy versus best supportive care for extensive small cell lung cancer. Cochrane Database Syst Rev. 2009;4:CD001990.

    Google Scholar 

  • Perez EA, Koniaris LG, Snell SE, Gutierrez JC, Sumner WE, Lee DJ, Hodgson NC, Livingstone AS, Franceschi D. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg. 2007;31:1022–30.

    Article  PubMed  Google Scholar 

  • Pinsky PF, Gierada DS, Hocking W, Patz EF, Kramer BS. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med. 2014;161:627–33.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E. Performance of lung-RADS in the National Lung Screening Trial: a retrospective assessment performance of Lung-RADS in the NLST. Ann Intern Med. 2015;162:485–91.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non–small-cell lung cancer guideline. J Clin Oncol. 2007;25:5506–18.

    Article  PubMed  Google Scholar 

  • Pope III CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132–41.

    Article  Google Scholar 

  • Postma DS, Rabe KF. The asthma–COPD overlap syndrome. N Engl J Med. 2015;373:1241–9.

    Article  CAS  PubMed  Google Scholar 

  • Presley CJ, Gross CP, Lilenbaum RC. Optimizing treatment risk and benefit for elderly patients with advanced non–small-cell lung cancer: the right treatment for the right patient. J Clin Oncol. 2016;34:1438–42.

    Article  CAS  PubMed  Google Scholar 

  • Quanjer PH, Tammeling G, Cotes J, Pedersen O, Peslin R, Yernault J. Lung volumes and forced ventilatory flows. European Respiratory Society. Rev Mal Respir. 1993.

    Google Scholar 

  • Quoix E, Zalcman G, Oster J-P, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet P-J, Bigay-Game L. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet. 2011;378:1079–88.

    Article  CAS  PubMed  Google Scholar 

  • Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:810–6.

    Article  PubMed  Google Scholar 

  • Ramalingam SS, Dahlberg SE, Langer CJ, Gray R, Belani CP, Brahmer JR, Sandler AB, Schiller JH, Johnson DH. Outcomes for elderly, advanced-stage non–small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of eastern cooperative oncology group trial 4599. J Clin Oncol. 2008;26:60–5.

    Article  CAS  PubMed  Google Scholar 

  • Read WL, Mortimer JE, Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer. 2002;94:847–53.

    Article  PubMed  Google Scholar 

  • Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S. Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer. N Engl J Med. 2016;375:1823–33.

    Article  CAS  PubMed  Google Scholar 

  • Richeldi L, Du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–82.

    Article  CAS  PubMed  Google Scholar 

  • Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2013;143:E142s–65s.

    Article  Google Scholar 

  • Robbins M, Greene-Schloesser D, Peiffer AM, Shaw E, Chan MD, Wheeler KT. Radiation-induced brain injury: a review. Front Oncol. 2012;2:73.

    PubMed  PubMed Central  Google Scholar 

  • Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012;13:239–46.

    Article  CAS  PubMed  Google Scholar 

  • Rudin CM, Ismaila N, Hann CL, Malhotra N, Movsas B, Norris K, Pietanza MC, Ramalingam SS, Turrisi III AT, Giaccone G. Treatment of small-cell lung cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians guideline. J Clin Oncol. 2015;33:4106–11.

    Article  CAS  PubMed  Google Scholar 

  • Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009;27:1579–84.

    Article  PubMed  Google Scholar 

  • Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxel–carboplatin alone or with bevacizumab for non–small-cell lung cancer. N Engl J Med. 2006;355:2542–50.

    Article  CAS  PubMed  Google Scholar 

  • Scagliotti GV, Parikh P, Von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non–small-cell lung cancer. J Clin Oncol. 2008;26:3543–51.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt CD, Dickman ML, Gardner RM, Brough FK. Spirometric standards for healthy elderly men and women 1–3: 532 subjects, ages 55 through 94 years. Am Rev Respir Dis. 1973;108:933–9.

    CAS  PubMed  Google Scholar 

  • Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;11:CD009519.

    Google Scholar 

  • Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12:26.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shaw AT, Kim D-W, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T. Ceritinib in ALK-rearranged non–small-cell lung cancer. N Engl J Med. 2014;370:1189–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, Swisher SG, Smith BD. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non–small cell lung cancers in the elderly. JAMA Surg. 2014;149:1244–53.

    Article  PubMed  PubMed Central  Google Scholar 

  • Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2013;143:E211s–50s.

    Article  Google Scholar 

  • Simoff MJ, Lally B, Slade MG, Goldberg WG, Lee P, Michaud GC, Wahidi MM, Chawla M. Symptom management in patients with lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J. 2013;143:E455s–97s.

    Article  CAS  Google Scholar 

  • Singer JP, Diamond JM, Gries CJ, Mcdonnough J, Blanc PD, Shah R, Dean MY, Hersh B, Wolters PJ, Tokman S, Arcasoy SM, Ramphal K, Greenland JR, Smith N, Heffernan P, Shah L, Shrestha P, Golden JA, Blumenthal NP, Huang D, Sonett J, Hays S, Oyster M, Katz PP, Robbins H, Brown M, Leard LE, Kukreja J, Bacchetta M, Bush E, D’ovidio F, Rushefski M, Raza K, Christie JD, Lederer DJ. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med. 2015;192:1325–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singer JP, Lederer DJ, Baldwin MR. Frailty in pulmonary and critical care medicine. Ann Am Thorac Soc. 2016;13:1394–404.

    Article  PubMed  PubMed Central  Google Scholar 

  • Skloot GS, Busse PJ, Braman SS, Kovacs EJ, Dixon AE, Vaz Fragoso CA, Scichilone N, Prakash Y, Pabelick CM, Mathur SK. An official American Thoracic Society workshop report: evaluation and management of asthma in the elderly. Ann Am Thorac Soc. 2016;13:2064–77.

    Article  PubMed  PubMed Central  Google Scholar 

  • Solomon BJ, Mok T, Kim D-W, Wu Y-L, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167–77.

    Article  PubMed  CAS  Google Scholar 

  • Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379–92.

    Article  CAS  PubMed  Google Scholar 

  • Spiro SG, Gould MK, Colice GL. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines. Chest J. 2007;132:149s–60s.

    Article  Google Scholar 

  • Team, N. L. S. T. R. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;2011:395–409.

    Google Scholar 

  • Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF. Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med. 2010;363:733–42.

    Article  CAS  PubMed  Google Scholar 

  • Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, Van Leeuwen FE, Holowaty E. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst. 2002;94:182–92.

    Article  PubMed  Google Scholar 

  • Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–85.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tsiouris A, Hammoud ZT, Velanovich V, Hodari A, Borgi J, Rubinfeld I. A modified frailty index to assess morbidity and mortality after lobectomy. J Surg Res. 2013;183:40–6.

    Article  PubMed  Google Scholar 

  • Van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, Van Zandwijk N. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non–small-cell lung cancer. J Natl Cancer Inst. 2007;99:442–50.

    Article  PubMed  Google Scholar 

  • Van Meter ME, Mckee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 2011;26:70–6.

    Article  PubMed  Google Scholar 

  • Van Zandwijk N, Clarke C, Henderson D, Musk AW, Fong K, Nowak A, Loeragan R, Mccaughan B, Boyer M, Feigen M. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5:E254–307.

    PubMed  PubMed Central  Google Scholar 

  • Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35:496–504.

    Article  CAS  PubMed  Google Scholar 

  • Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, Van Empel VP, Bruijnzeel PL, Rutten EP, Op’t Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728–35.

    Article  PubMed  Google Scholar 

  • Vaz Fragoso CA, Mcavay G, Van Ness PH, Casaburi R, Jensen RL, Macintyre N, Gill TM, Yaggi HK, Concato J. Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med. 2015;192:817–25.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184–92.

    Article  CAS  PubMed  Google Scholar 

  • WHO. Global health estimates 2015: deaths by cause, age, sex, by country and by region, 2000–2015. Geneva: World Health Organization; 2016.

    Google Scholar 

  • Yasufuku K, Chiyo M, Koh E, Moriya Y, Iyoda A, Sekine Y, Shibuya K, Iizasa T, Fujisawa T. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer. 2005;50:347–54.

    Article  PubMed  Google Scholar 

  • Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble G. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Funding support for LW is provided by the NIH funded Research Training in Respiratory Biology grant at the University of Chicago (T32 HL007605). Funding support for CP is provided by the Robert Wood Johnson Foundation/Veteran’s Health Administration Clinical Scholars Program, The Conquer Cancer Foundation, and Yale University SPORE in lung cancer grant P50CA196530.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leah J. Witt .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Witt, L.J., Presley, C.J. (2018). Respiratory Organ Aging and Cancer. In: Extermann, M. (eds) Geriatric Oncology . Springer, Cham. https://doi.org/10.1007/978-3-319-44870-1_63-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44870-1_63-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44870-1

  • Online ISBN: 978-3-319-44870-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics